ABVC

MKT CAP:$35M

ABVC Biopharma Inc

Market Cap

$35M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.33-$0.86 (-39.27%)

Jun 5, 2026

52W High $4.7452W Low $0.91

Company Details

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combinat...

CEO

—

IPO Date

Oct 11, 2017

Website

www.abvcpharma.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$9M

EPS (Diluted)

Free Cash Flow

-$3M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 18, 2026

$0-100.0%

FY 2025

Mar 3, 2026

$796.0K+56.2%

Q4 2025

Mar 3, 2026

-$796.0K-40585.8%

Q3 2025

Nov 3, 2025

$796.0K+104.5%

Q2 2025

Aug 13, 2025

$0-100.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee